NCT00235794View on ClinicalTrials.gov

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

September 30, 2007

Conditions
Prostatic Neoplasms
Interventions
DRUG

temsirolimus

Trial Locations (1)

77030

Houston

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00235794 - An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients | Biotech Hunter | Biotech Hunter